MétaCan
Menu
Back to cohort
Record W4415434131 · doi:10.1093/ndt/gfaf116.1237

#622 An atypical case of atypical HUS

2025· article· en· W4415434131 on OpenAlexaff
Shannon Wong, Susanna A. McRae

Bibliographic record

VenueNephrology Dialysis Transplantation · 2025
Typearticle
Languageen
FieldImmunology and Microbiology
TopicComplement system in diseases
Canadian institutionsUniversity of British Columbia
Fundersnot available
KeywordsThrombotic microangiopathyAtypical hemolytic uremic syndromeEculizumabMicroangiopathic hemolytic anemiaRenal functionDialysisRenal biopsyNephropathyHemolytic anemiaGenetic testing

Abstract

fetched live from OpenAlex

Abstract Background and Aims Atypical HUS (aHUS) is a rare form of thrombotic microangiopathy (TMA) that results in complement-mediated damage of the microvascular endothelium, with renal impairment being the most common manifestation. Genetic defects result in over-activation of the alternative complement cascade and complement factor H (CFH) mutations are the most commonly detected. Due to incomplete penetrance, external factors ultimately trigger clinical manifestations of this disease in those who are genetically predisposed. Here, we describe an atypical first presentation of aHUS in an elderly female patient with rapidly worsening renal function and no obvious precipitating factor. She was successfully treated with eculizumab, a terminal complement cascade inhibitor, with biochemical improvement in her hemolytic parameters and renal function. Genetic testing later confirmed the presence of a pathogenic CFH mutation. This case highlights the role of genetic testing in all cases of suspected aHUS. Results A previously healthy 82-year-old female with normal baseline renal function presented to hospital with lower gastrointestinal bleeding and developed microangiopathic hemolytic anemia and rapidly worsening renal function requiring dialysis initiation. A renal biopsy demonstrated features compatible with thrombotic microangiopathy (Fig. 1). An extensive TMA workup including infectious panels, autoimmune serologies, malignancy screening, and ADAMTS levels returned normal. Eculizumab approval was acquired on an expedited basis and she was started on treatment. Two months later, her renal function and hemolytic parameters improved to the point of dialysis discontinuation. Her Blueprint Genetics HUS panel later returned, showing a pathogenic heterozygous missense variant of CFH. In light of her positive CFH genetic variant, she has received approval for ongoing eculizumab treatment and her case will be reviewed by the Ministry of Health annually for ongoing medication renewal. Conclusion Although aHUS is a rare condition, it is associated with a poor prognosis, with estimates of progression to end stage renal disease or death ranging between 50 to 80%, respectively [1]. The median initial age of aHUS presentation is 35 years old, with infection, pregnancy, autoimmune disease, and malignancy considered common precipitating factors for this disease [2]. This is an unusual case of a patient with a pathogenic CFH mutation who developed her first presentation of aHUS at age 82 with no clear precipitating factor. This case highlights the importance of considering the diagnosis of aHUS in patients with TMA, and the utility of genetic testing in helping to guide treatment for those with suspected aHUS.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.651
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.283
Teacher spread0.270 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNephrology Dialysis TransplantationSame topicComplement system in diseasesFrench-language works237,207